Bangkok--22 Dec--Francom Asia
Nioxin Research Laboratories announces its success in developing the first genetic test that determines the likelihood of developing male pattern baldness before it actually begins to happen.
This genetic test is a collaboration between Nioxin, the leader in professional skincare for the hair and scalp, and HairDX, a US-based biotech start-up, to develop scientifically proven scalp and hair products that offer optimum results. It will help men assess their risk and genetic predisposition for developing pattern baldness. The test in full version can be viewed at www.nioxin.com.
How it works:
The participant simply swabs their mouth (inside cheek) for several seconds and returns the swab in a sealed pack to the HairDX lab. A confidential and anonymous genetic analysis of the individual’s genetic variations is performed, related to pattern baldness. The confidential results are delivered via a secure website.
Professor Doron Lancet, PhD, a pioneer of genome research and Head of the Crown Human Genome Centre at the Department of Molecular Genetics, Weizmann Institute of Science in Rehovot, Israel, says, “Hair DX tests for a genetic variant found in more than 95% of bald men. 60% of patients with this variant experienced male pattern baldness before the age of 40, thus it is a marker for a significant risk of pattern baldness. This is in contrast to the less common genetic variant of the same age, present in about 1 in 6 people, which indicates greater than 85% likelihood that a person will not experience early onset pattern baldness.”
“Gaining a better understanding of the potential cause of an individual’s condition enables a more accurate assessment of the most appropriate solution,” says Eva Graham, founder of Nioxin Research Laboratories.
With a deep insight into concerns about fine and thinning hair, Nioxin has developed the NIOXIN 3-Part System, an ultimate solution to nourish hair and scalp condition in prevention of hair loss and baldness. Apart from fortifying hair follicles and scalp environment with vital nutrients, Nioxin’s Transactive Delivery System helps shields pollutants and DHT (the converted form of Testosterone hormones which cause hair follicles to shrink and progressively produce finer hairs that fall off at last.) on the scalp. NIOXIN 3-Part System provides four sets of products to suit different characteristics of hair:
? System 1 for fine hair
? System 3 for fine and chemical-enhanced hair
? System 5 for coarse hair
? System 7 for coarse and chemical-enhanced hair
Today, with the collaboration, experience and expertise of these two companies, men can actually take action to help prevent premature balding. Thanks to scientific information, they can make the right decisions about their hair and scalp care products to ensure that they get the right treatment or restoration, and by doing so, they maintain their youthful looks.
- Nioxin is the leading provider of advanced hair and scalp treatments to improve the appearance of fine and thinning hair. Founded in 1987 by Eva Graham, this privately-held company has been dedicated to providing education and products for consumer through the professional salon industry around the world. Distributed in more than 42 countries on six countries, Nioxin continues to define the meaning of innovation and leadership for the global market of fine and thinning hair. More information is available at www.nioxin.com
- Based in Irvine, CA, HairDX was founded by leading researchers and specialists in genetic analysis and hair therapies. The company is dedicated to helping people make the right decisions about hair care, treatment and restoration by providing accurate and accessible personalized scientific information. More information is available at www.hairdx.com
For more information, please contact:
Khun Suwanna Thanawiwatchai
Press Information Service of Nioxin
C/o Francom Asia
Tel 02-233 4329-30 Fax. 02-236 8030
E-mail: [email protected]